Health & Biotech
Weed Week: New studies confirm cannabis alleviates cancer pain, cuts need for opioids, and improves sleep
Dimerix launches $12 million cap raise to advance Phase 3 trial for kidney drug
PharmAust’s oversubscribed $2.5m placement highlights investor backing
ASX Health Stocks: Proteomics’ blood test PromarkerD effective with diabetes drug Canagliflozin
Incannex achieves major milestone as anti-inflammatory drug well tolerated in Phase-1 trial
MGC Pharma’s Malta facility is now GMP certified, opening door to markets such as the US
Stock Insiders: Nova Eye Medical surges 20pc after FDA clears glaucoma treatment
Creso’s Canadian cannabis subsidiary expands into 8th province
Nova’s updated iTrack Advance glaucoma device officially enters US market
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales
ScoPo’s (actually still Iain’s) Powerplays: ASX health sector falls, but several stocks on upward run
PharmAust delivers positive motor neurone disease Phase-1/2 trial update, giving hope to sufferers with drug well-tolerated
Unicorns Podcast: Control Bionics (ASX CBL) leading the world in life-changing technology
Could these Aussie psychedelics stocks carve a slice out of a ‘potential $63 billion’ global market?
MST upgrades CardieX to 5x current share price as FDA green lights world-first vascular biometric monitor
EZZ healthy as delivers strong Q3 FY23 results including 30% rise in cash receipts and operating cash flows up by 371%
Blood Pressure Breakthrough: CardieX gets FDA green light for world-first vascular biometric monitor
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
